If your taste in rock runs to the adventurous side, the Burren tonight is the place to be. Featured will be the lush pop of ...

Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...

At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...

Research team developed PathActMarker, a software package for pathway activity inference and analysis. It preprocesses gene expression data, converts it into pathway activity matrices using eight ...

R&D Expenses: Research and development expenses for the year ended December 31, 2024 were $38.8 million, compared to $40.6 million for the year ended December 31, 2023. The decrease was primarily due ...

Japanese researchers used a nonviral piggyBac system to genetically modify cynomolgus monkeys, enabling more accurate disease ...

Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death of a patient taking Sarepta’s Elevidys raises important safety questions.

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...

Researchers at University of Tsukuba have developed "tomoseqr"—a new software tool that enables easy estimation of the ...

Genetic engineering in non-human primates has historically faced limitations due to the reliance on virus-based gene delivery methods.

Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are ...

Genetic engineering in non-human primates has long been limited by the need for virus-based gene delivery methods. Recently, ...